Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China
· Delayed Price · Currency is CNY 18.22
+0.21 (1.17%)
Mar 9, 2026, 3:04 PM CST
SHE:002317 Revenue
Guangdong Zhongsheng Pharmaceutical had revenue of 589.02M CNY in the quarter ending September 30, 2025, with 8.35% growth. This brings the company's revenue in the last twelve months to 2.45B, up 0.04% year-over-year. In the year 2024, Guangdong Zhongsheng Pharmaceutical had annual revenue of 2.47B, down -5.48%.
Revenue (ttm)
2.45B
Revenue Growth
+0.04%
P/S Ratio
6.33
Revenue / Employee
1.38M
Employees
1,775
Market Cap
15.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.47B | -143.13M | -5.48% |
| Dec 31, 2023 | 2.61B | -65.60M | -2.45% |
| Jan 1, 2023 | 2.68B | 247.06M | 10.17% |
| Jan 1, 2022 | 2.43B | 533.27M | 28.13% |
| Dec 31, 2020 | 1.90B | -635.69M | -25.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 5.38B |
| Hybio Pharmaceutical | 898.10M |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 4.24B |
| Nanjing King-Friend Biochemical Pharmaceutical | 3.76B |
| Shenzhen Kangtai Biological Products | 2.70B |
| Zhejiang Jiuzhou Pharmaceutical | 5.36B |
| Guobang Pharma | 5.94B |
| Shanghai Shyndec Pharmaceutical | 9.36B |